Cite
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.
MLA
Karasavvas, Nicos, et al. “IgG Antibody Responses to Recombinant Gp120 Proteins, Gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.” AIDS Research & Human Retroviruses, vol. 31, no. 11, Nov. 2015, pp. 1178–86. EBSCOhost, https://doi.org/10.1089/aid.2015.0034.
APA
Karasavvas, N., Karnasuta, C., Savadsuk, H., Madnote, S., Inthawong, D., Chantakulkij, S., Rittiroongrad, S., Nitayaphan, S., Pitisuttithum, P., Thongcharoen, P., Siriyanon, V., Andrews, C. A., Barnett, S. W., Tartaglia, J., Sinangil, F., Francis, D. P., Robb, M. L., Michael, N. L., Ngauy, V., & de Souza, M. S. (2015). IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens. AIDS Research & Human Retroviruses, 31(11), 1178–1186. https://doi.org/10.1089/aid.2015.0034
Chicago
Karasavvas, Nicos, Chitraporn Karnasuta, Hathairat Savadsuk, Sirinan Madnote, Dutsadee Inthawong, Somsak Chantakulkij, Surawach Rittiroongrad, et al. 2015. “IgG Antibody Responses to Recombinant Gp120 Proteins, Gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.” AIDS Research & Human Retroviruses 31 (11): 1178–86. doi:10.1089/aid.2015.0034.